NCT02542462View on ClinicalTrials.gov

Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
IntussusceptionRotavirus Infections
Interventions
DRUG

Rotarix®,

Single oral dose of licensed rotavirus vaccine given alone

DRUG

Rotarix®, with other routine vaccines

Single oral dose of licensed rotavirus vaccine given with other routine vaccines

DRUG

RotaTeq®,

Single oral dose of licensed rotavirus vaccine given alone

DRUG

RotaTeq®, with other routine vaccines

Single oral dose of licensed rotavirus vaccine given with other routine vaccines

Trial Locations (1)

45219

Cincinnati Children's Hosptital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02542462 - Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study | Biotech Hunter | Biotech Hunter